Sangamo Therapeutics Announces Participation at the Jefferies 2019 London Healthcare Conference
BRISBANE, Calif.--(BUSINESS WIRE)--Nov 18, 2019--
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21 at 4:40 p.m. GMT in London, UK.
The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191118005718/en/
CONTACT: Investor Relations – Global
email@example.comMedia Inquiries – Global
KEYWORD: CALIFORNIA EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA
INDUSTRY KEYWORD: HEALTH STEM CELLS GENETICS RESEARCH SCIENCE BIOTECHNOLOGY
SOURCE: Sangamo Therapeutics, Inc.
Copyright Business Wire 2019.
PUB: 11/18/2019 04:05 PM/DISC: 11/18/2019 04:05 PM